TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ +0.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow OGN
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
32.6% 37.7% 35.6% 33.5% 39.0% 13.9% 12.8% 14.7% 11.3%
18.8% 17.1% 4.3% 2.2% 3.1% 3.4% 3.8% 4.3% 5.8%
0.5% 0.6% 0.5% 0.6% 0.9% 1.2% 1.6% 1.6% 1.2%
10.8% 0.4% 1.4% 1.0% 3.3% 2.9%
-13.7% -1.8% -8.6% -3.0% 11.1% -7.3% -2.5% -4.3% -4.0%
0.8% 1.0% 1.2% 4.3% 7.7% 6.9% 4.2% 5.5% 2.6%
-0.5% -0.7% -1.3% -3.9% -7.6% -6.8% -4.2% -8.0% -6.3%
1.5% 1.9% 2.2% 2.3% 4.7% 4.7% 4.6% 1.4%
-0.2% -0.3% -0.3%
0.0% 0.6% -0.6% 17.8% 122.6% -1.7% -4.1% -0.2% -7.4%
-32.1% -42.6% -33.7% -33.3% -21.1% -7.0% -9.1% -5.7% -9.0%
-0.4% -5.4% 1.0% -3.8% 10.6% -0.5% -0.2% -0.3% -1.6%
31.7% 36.7% 34.4% 29.2% 31.3% 7.0% 8.6% 9.2% 8.7%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?